Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection—What Do We Know, and What More Do We Need to Know?

When treating patients with CKD on hemodialysis with active infection, a key tenet is do no harm. CKD is a major public health problem that consumes a disproportionate and increasing share of health care resources. Treating CKD was estimated to cost Medicare $44.6 billion in 2014, although there is